CRISPR Co-Founder Jennifer Doudna on Future of Biotech

Video News
Sixth Street Chief Science Adviser and Nobel laureate Jennifer Doudna, co-founder of the CRISPR genome editing technology 10 years ago, and Sixth Street Vice Chairman and Partner R. Martin Chavez join Emily Chang to discuss the future of CRISPR and its potential for commercialization.

Products You May Like

Leave a Reply

Your email address will not be published. Required fields are marked *